These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4204467)

  • 1. [Value of mandelamine in the prolonged treatment of urinary infections caused by escherichia coli].
    Scetbon V; Peycelon-de la Selle MF
    Therapeutique; 1973 Apr; 49(4):283-6. PubMed ID: 4204467
    [No Abstract]   [Full Text] [Related]  

  • 2. Methenamine hippurate in the treatment of urinary tract infections.
    Kasanen A; Mustakallio E; Koskinen EH; Soini V
    Ann Clin Res; 1974 Oct; 6(5):279-84. PubMed ID: 4614694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mandelamine].
    Chrapowicki T; Krzyzanowska-Rogozińska T; Kurowska D
    Pol Tyg Lek; 1975 May; 30(21):909-12. PubMed ID: 1135063
    [No Abstract]   [Full Text] [Related]  

  • 4. Methenamine hippurate (Hiprex).
    Med Lett Drugs Ther; 1968 Jul; 10(15):58-60. PubMed ID: 4875552
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical testing of methenamine hippurate (Hiprex) in the treatment of urinary tract infections].
    Bengtsson U; Orsten PA
    Lakartidningen; 1973 Dec; 70(49):4517-9. PubMed ID: 4595775
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.
    Cohen AE; Lautenbach E; Morales KH; Linkin DR
    Am J Med; 2006 Nov; 119(11):958-63. PubMed ID: 17071164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute and chronic urinary tract infections in children with an urinary chemotherapeutic agent].
    Chrapowicki T; Krzyzanowska-Rogozińska T; Kurowska D
    Z Allgemeinmed; 1975 Sep; 51(27):1215-9. PubMed ID: 1105992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of urinary tract infections in children].
    Nowak S; Planeta-Malecka I; Bodalski J; Narebska E; Kozlowski J; Kostenko D
    Wiad Lek; 1975 Aug; 28(16):1367-73. PubMed ID: 1163019
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection.
    Kasanen A; Kaarsalo E; Hiltunen R; Soini V
    Ann Clin Res; 1974 Oct; 6(5):285-9. PubMed ID: 4475571
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a combined therapy in the treatment and prophylaxis of urinary infections.
    Shuman FI; Goldberg RI
    Conn Med; 1965 Oct; 29(10):713-5. PubMed ID: 5319028
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfametopyrazine single-dose treatment of urinary tract infections n general practice.
    Windsor BP; Langsdale GA; Hill J; Hooper WL; Allen HA
    Br J Clin Pract; 1973 Jan; 27(1):15-7. PubMed ID: 4568133
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of urinary tract infections with sulfacytine, a new soluble sulfonamide.
    Moffat NA; Wenzel FJ
    Curr Ther Res Clin Exp; 1971 May; 13(5):286-91. PubMed ID: 4998391
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methenamine hippurate in urinary tract infections].
    Klein D; Puchegger R
    ZFA (Stuttgart); 1976 Jul; 52(21):1110-4. PubMed ID: 785852
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
    Gow JG
    Practitioner; 1974 Jul; 213(1273):97-101. PubMed ID: 4280569
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of urinary infections with amoxycillin].
    Peromet M; Schoutens E; Yourassowsky E
    Chemotherapy; 1973; 18():Suppl:52-6. PubMed ID: 4576489
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of chronic urinary tract infection: clinical experience with hippramine].
    Mitsuya H; Kondo A
    Hinyokika Kiyo; 1968 Jan; 14(1):57-77. PubMed ID: 4878096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination of trimethoprim and sulfamethoxazole in coliform urinary infections].
    Langlois Y; Mélançon J; Tétreault L
    Union Med Can; 1973 Feb; 102(2):395-9. PubMed ID: 4575499
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic sensitivity and immediate clinical response in urinary tract infections].
    Bugnon A; Sakellaridès E; Schelling JL; Bonifas V
    Schweiz Med Wochenschr; 1972 Oct; 102(40):1407-11. PubMed ID: 4567937
    [No Abstract]   [Full Text] [Related]  

  • 20. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.